| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8780852 | Gynecologic Oncology | 2017 | 5 Pages |
Abstract
This represents the largest single-institution study for modern stage II endometrial cancer, confirming high rates of pelvic disease control after surgery and adjuvant therapy. With most patients receiving adjuvant radiotherapy, the predominant mode of failure, albeit low in absolute number, remains distant metastases.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Katherine S. Chen, Hebist Berhane, Beant S. Gill, Alexander Olawaiye, Paniti Sukumvanich, Joseph L. Kelley, Michelle M. Boisen, Madeleine Courtney-Brooks, John T. Comerci, Robert Edwards, Jessica Berger, Sushil Beriwal,